Zika virus: FDA recommends ban on blood collections from affected areas

The US Food and Drug Administration (FDA) has recommended that blood no longer be collected from regions where the Zika virus is circulating, and that blood needed for transfusions be obtained from areas of the United States without active transmission. The agency said blood banks can continue collecting and preparing platelets and plasma if an FDA-approved pathogen-reduction technology is used. Current pathogen-reduction technology is not approved to treat whole red blood. Feb 17, 2016
MOST POPULAR